SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Zelda Fitzgerald — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientZelda Fitzgerald
Date of birth1900-07-24
IdentifiersMRN HR-ET004-SYN-TD; SSN (made up) 000-04-8712
Document date1930-05-18
AuthorMargot Ellery, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

One-week review, seen the same day by psychiatry with the coordinated specialty care team. [S]

History of Present Illness

Ms. Fitzgerald returns one week after her first visit and is seen by Dr. Langford of the coordinated specialty care team on the same day. She takes risperidone 2 mg every night. She sleeps nine or ten hours and feels heavy and slow in the mornings. She has had no voices, no sense of being watched, and no racing thoughts. Her mood is still low but less tearful, and she has begun writing again for an hour a day. Her periods have still not returned; she has had no breast discharge. She is eating three small meals and has not danced. She is worried that medicines will make her gain weight and end her dancing. She has had no thoughts of suicide or self-harm. [S]

ElementDetail
Risperidone2 mg at bedtime, every dose taken
Psychotic and manic symptomsNone
MoodLow but improving; PHQ-9 9; item 9 scored 0
SleepNine or ten hours; slow in the mornings
PeriodsStill absent; no breast discharge
ConcernWeight gain and her dancing

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired in the mornings; weight stable
GenitourinaryPositiveNo periods for about five months; no pelvic pain
EndocrineNegativeNo breast discharge; no heat or cold intolerance
NeurologicalNegativeNo restlessness, stiffness, or tremor
PsychiatricPositiveLow mood, improving; no voices, racing thoughts, or thoughts of suicide or self-harm

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Risperidone 2 mg oral tablet, one tablet by mouth at bedtime (started in hospital)One tablet by mouth at bedtimeOral route1930-04-20 to 1930-06-08completedS
Lithium carbonate 300 mg oral capsule, one capsule by mouth twice dailyOne capsule by mouth twice dailyOral route1930-05-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1930-05-18Body height165cmS
1930-05-18Body weight51kgS
1930-05-18Body mass index (BMI) [Ratio]18.7kg/m2S
1930-05-18Systolic blood pressure106mm[Hg]S
1930-05-18Diastolic blood pressure66mm[Hg]S
1930-05-18Heart rate76/minS
1930-05-18Respiratory rate14/minS
1930-05-18Body temperature36.5CelS
1930-05-18Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1930-05-18Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S

Physical Exam

Vital signs recorded on 1930-05-18; see the Vital Signs section. [S]

SystemFinding
GeneralSlim and well; weight 51.0 kg, BMI 18.7; waist 66 cm; blood pressure 106/66, pulse 76
NeurologicalNo akathisia, rigidity, tremor, or abnormal movements; AIMS score 0
PsychiatricQuiet, reactive affect; organized; no psychotic or manic features; insight good

Problems

ProblemClinical statusVerificationCodeProvenance
First episode of psychosis with marked mood symptoms: about three weeks of little sleep, rapid speech, racing thoughts, grandiose plans and very long training days, then a voice commenting on her dancing and a belief that she was being watched and tested; tearful low mood since discharge. Diagnosis provisional; differential: bipolar I disorder with psychotic features, schizoaffective disorder (bipolar type), and schizophreniform disorder or schizophrenia, depending on whether the psychosis ever occurred apart from the mood symptoms. Synthetic modern episode linked to her documented first hospitalizationactiveprovisional F29S — Synthetic modern coding of the documented first breakdown. Unspecified psychosis is coded until the course shows how the psychosis relates to the mood symptoms; superseded at the three-month visit.
Secondary amenorrhea: no periods for about four months before admission, during very heavy dance training at a low weight (BMI 18.7), with prolactin raised on risperidone; pregnancy test negativeactiveconfirmed N91.1S — Synthetic presenting finding linked to her documented training; resolved when her periods returned.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
Medication safetyAntipsychotic dose, adherence, and responseEvery visitCompleted todayRisperidone 2 mg; full adherence; no psychotic or manic symptoms
SurveyManic, depressive, and psychotic symptoms, and early warning signsEvery visitCompleted todayNo manic or psychotic symptoms; depressive phase easing
ExaminationAkathisia, parkinsonism, and sedationEvery visit in the first months and after any dose changeCompleted todayMorning sedation; no akathisia or parkinsonism
ExaminationAbnormal Involuntary Movement Scale (AIMS)Baseline, then every 6 monthsCompleted todayBaseline AIMS score 0, done with the consultation
ExaminationWeight and BMIEvery visit for 6 months after starting or changing an antipsychotic (CMID: baseline, 4, 8, and 12 weeks, then quarterly)Completed today51.0 kg (BMI 18.7); waist 66 cm
ExaminationBlood pressureBaseline, 12 weeks, then yearlyCompleted today106/66
LaboratoryFasting glucose and A1cBaseline, 12 weeks to 4 months, then yearlyUp to dateGlucose 84 mg/dL and A1c 5.0% at intake; next at 12 weeks to 4 months
LaboratoryFasting lipid panelBaseline, 12 weeks to 4 months, then yearlyUp to dateNormal at intake; next at 12 weeks to 4 months
LaboratoryProlactinWhen there are symptoms of high prolactin, such as missed periodsUp to date62 ng/mL at intake with absent periods; repeat at the next check
LaboratoryElectrocardiogramBefore lithium if over 40 or with heart disease; before an antipsychotic with cardiac risk factorsNot indicatedAge 29, no heart disease, fainting, or family history of sudden death
LaboratoryCreatinine and eGFR on lithiumBaseline, every 2 to 3 months for 6 months, then every 6 to 12 monthsUp to dateBaseline creatinine 0.72 mg/dL, eGFR 116, a week ago
LaboratoryTSH on lithiumBaseline, once or twice in the first 6 months, then every 6 to 12 monthsUp to dateBaseline TSH 2.1 mIU/L a week ago
LaboratoryCalcium on lithiumBaseline, then yearlyUp to dateBaseline calcium 9.4 mg/dL a week ago
LaboratoryLithium level (12-hour trough)5 to 7 days after starting and after any change until stable, then every 3 to 6 monthsDueLithium started today; level ordered for 5 to 7 days from now
Medication safetyLithium side effects and sick-day rulesAt the start and every visitCompleted todayTremor, thirst, nausea and signs of toxicity explained; take with food; keep drinking normally; no anti-inflammatory painkillers
Medication safetyPregnancy prevention on lithium; valproate avoidedBefore starting and at each visit until a reliable method is in placeCompleted todayUrine pregnancy test negative today; valproate avoided; the small risk of heart defects with lithium early in pregnancy explained; condoms reliably for now
SurveyDepression measure (PHQ-9)Monthly during acute treatment, every 2 to 4 weeks in continuation, then periodicallyCompleted todayPHQ-9 9, from 11; item 9 scored 0
SurveySuicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; safety plan reviewed; no firearm access; lithium dispensed two weeks at a time
Self-managementSleepEvery visitCompleted todayNine or ten hours on risperidone; regular times agreed
Self-managementEating, exercise, and periodsEvery visit while periods are absent or weight is lowCompleted todaySCOFF 1 of 5 a week ago; three small meals; not dancing; periods absent; dietitian arranged
ReferralPsychiatry consultationAt the start of treatment for a first episodeCompleted todaySeen by Dr. Langford today
Self-managementCoordinated specialty care engagementOngoing, for up to two to three yearsCompleted todayEnrolled today

Goal progress:

Guideline basis: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018); The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence (2023); The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Consensus development conference on antipsychotic drugs and obesity and diabetes (2004); Recovery After an Initial Schizophrenia Episode (RAISE): coordinated specialty care for first-episode psychosis (2026); U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (2024); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: Lithium level in 5 to 7 days at the laboratory. Visit in three weeks with lithium level, creatinine, electrolytes, prolactin, and the PHQ-9. Care coordinator weekly; dietitian next week. Next scheduled visit 1930-06-08: lithium level after the sick visit, prolactin, and the antipsychotic plan. [S]